T-cell-mediated immunity

Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.
Related to T-cell-mediated immunity: humoral immunity


(im-u'nit-e) [L. immunitas, exemption]
Protection from diseases, esp. from infectious diseases. See: immune response; immune system; immunization; vaccine

acquired immunity

Immunity owing to exposure to an antigen or to the passive injection of immunoglobulins.

active immunity

Immunity resulting from the development within the body of antibodies or sensitized T lymphocytes that neutralize or destroy the infective agent. This may result from the immune response to an invading organism or from inoculation with a vaccine containing a foreign antigen.
See: immune response; vaccination

adaptive immunity

The component of immunity that is pathogen-specific and creates memory. It consists of the mechanisms of cell-mediated and antibody-mediated immunity.
See: innate immunity

B-cell–mediated immunity

Humoral immunity.
Enlarge picture

cell-mediated immunity

Abbreviation: CMI.
The regulatory and cytotoxic activities of T cells during the specific immune response. This process requires about 36 hr to reach its full effect. Synonym: T-cell–mediated immunity See: illustration; humoral immunity

Unlike B cells, T cells cannot recognize foreign antigens on their own. Foreign antigens are recognized by antigen-presenting cells (APCs) such as macrophages, which engulf them and display part of the antigens on the APC's surface next to a histocompatibility or “self-” antigen (macrophage processing). The presence of these two markers, plus the cytokine interleukin-1 (IL-1) secreted by the APCs activates CD4 helper T cells (TH cells), which regulate the activities of other cells involved in the immune response.

CMI includes direct lysis of target cells by cytotoxic T cells, creation of memory cells that trigger a rapid response when a foreign antigen is encountered for the second time, and delayed hypersensitivity to tissue and organ transplants. T cells also stimulate the activity of macrophages, B cells, and natural killer cells. These functions are controlled largely by the secretion of lymphokines such as the interleukins, interferons, and colony-stimulating factors. Lymphokines facilitate communication and proliferation of the cells in the immune system.

cellular immunity

T-cell–mediated immune functions requiring cell interactions, e.g., graft rejection or destruction of infected cells.
See: cellular immunity

cocoon immunity

Vaccination of all the household contacts of an infant against those infectious diseases that he or she might contract. It is designed to protect disease-naive newborns from potentially fatal contagious illnesses. Synonym: cocoon strategy.

community immunity

Herd immunity.

congenital immunity

Immunity present at birth. It may be natural or acquired, the latter depending on antibodies received from the mother's blood.

herd immunity

The ability of a community to resist epidemic disease. Herd immunity may develop naturally in a society as a result of widespread exposure to disease, or it may be stimulated artificially by mass vaccination programs.

Patient care

Members of every region or community should be alerted to local or widespread communicable diseases for which vaccination is available. Offering public immunization sessions through local health departments, schools, colleges and places of business, as well as public and private health care agencies will increase the percentage of persons who are vaccinated and will decrease risk of communicable disease epidemics.

Synonym: community immunity
Enlarge picture

humoral immunity

The protective activities of antibodies against infection or reinfection by common organisms, e.g., streptococci and staphylococci. B lymphocytes with receptors to a specific antigen react when they encounter that antigen by producing plasma cells (which produce antigen-specific antibodies) and memory cells (which enable the body to produce these antibodies quickly in the event that the same antigen appears later). B-cell differentiation also is stimulated by interleukin-2 (IL-2) secreted by CD4+ T cells and foreign antigens processed by macrophages.

Antibodies produced by plasma B cells, found mainly in the blood, spleen, and lymph nodes, neutralize or destroy antigens in several ways. They kill organisms by activating the complement system; neutralize viruses and toxins released by bacteria; coat the antigen (opsonization) or form an antigen-antibody complex to stimulate phagocytosis; promote antigen clumping (agglutination); and prevent the antigen from adhering to host cells.

Synonym: B-cell–mediated immunity See: illustration; cell-mediated immunity; immunoglobulin

innate immunity

Those immune defenses against infection and cancer that are not determined by the specific responses of B or T lymphocytes. Innate immunity is not pathogen-specific and does not create immunological memory. It includes the actions of adhesion molecules; cellular chemotaxis; the secretion of cytokines; cytotoxicity; the activities of dendritic and natural killer cells; inflammation; and phagocytosis. Synonym: innate immune system

local immunity

Immunity limited to a given area or tissue of the body.

natural immunity

Immunity that is genetically determined in specific species, populations, or families. Some pathogens cannot infect certain species because the cells do not provide suitable environments. For example, the measles virus cannot reproduce in canine cells and therefore dogs have natural immunity to measles.

passive immunity

Immunity acquired by the introduction of preformed antibodies into an unprotected individual. This can occur through intravenous infusion of immune globulin or from antibodies that pass from the mother to the fetus through the placenta in utero. Newborns also may acquire immunity through breastfeeding.

T-cell–mediated immunity

Cell-mediated immunity.

waning immunity

The progressive loss of protective antibodies against an antigen or disease that occurs with the passage of time. It is a crucial factor in vaccination. Booster doses of a vaccine are given when the immune response to an antigen drops below protective levels.
References in periodicals archive ?
The findings of the comparison of T-cell-mediated immunity in healthy persons and patients with gastric cancer before the treatment were typical for patients with malignant neoplasms-T-cell deficiency with reduced T helper cell subpopulation, increased rate of immature lymphocytes, and disruption of the immune regulation ratio (T helper cells/regulatory T cells).
Much has been studied in the recent past about their association with RTIs, but it has always remained a biased hypothesis.1 These chronic conditions compromise the immune system by impairing the neutrophil function as well as T-cell-mediated immunity. They also depress antioxidant system and humoral immunity.7,10 SP-D secreted by type II pneumocytes is hypothesised to be associated with pulmonary host defences.
Hakem et al., "Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity," Genes and Development, vol.